Ben is a Senior Regulatory Affairs Consultant at SFL.
He supports SFL’s clients with global regulatory strategy, with a focus on interactions with the EMA. Ben has more than 25 years experience working in regulatory affairs. He has held senior regulatory roles in both large and small pharma organizations, including biotech, and has a track record of success in developing robust regulatory strategies for medicinal products in development. He has significant experience with oncology, orphan disease and gene therapy products.
Ben holds a BSc in Biological and Medicinal Chemistry from the University of Essex, UK and a MPhil in Biochemistry from Guys Hospital, London (now part of the Kings College London), UK.